Interbody Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Interbody Devices Pipeline Market Report Overview

Interbody fusion cage devices use hollow threaded titanium or carbon fiber cylinder. It is used to fuse two vertebrae to treat degenerative disc disease to provide fixation. During the surgery process, the diseased/ruptured vertebral disc is replaced by interbody cages.

Interbody devices are made up of materials such as metals usually titanium, machined bone allograft, PEEK (polyetheretherketone), and others which include ceramics and carbon fiber. Depending upon the surgical approach followed, thoracolumbar spinal procedures involving interbody devices are divided into four types namely Anterior lumbar interbody fusion (ALIF), Posterior lumbar interbody fusion (PLIF), Transforaminal lumbar interbody fusion (TLIF) and Lateral lumbar interbody fusion (LLIF).

The interbody devices pipeline market research report provides comprehensive information about the Interbody Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       PEEK Interbody Devices

·       Metal Interbody Devices

·       Other Interbody Devices (Ceramic, Carbon Fibre)

·       Machined Allograft Bone Interbody Devices

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       United Kingdom

Key Regulatory Paths ·       510(k)

·       PMA

·       CE

·       NMPA

·       TGA

Leading Companies ·       3D Systems Inc

·       Acuitive Technologies Inc

·       Allegra Orthopaedics Ltd

·       ALM Ortho Inc

·       Alphatec Holdings Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Interbody Devices Pipeline Market by Segments

The key segments in the interbody devices market are PEEK Interbody Devices, Metal Interbody Devices, Other Interbody Devices (Ceramic, Carbon Fibre), and Machined Allograft Bone Interbody Devices. As of July 2023, the PEEK Interbody Devices segment had the highest number of pipeline products.

Interbody Devices Pipeline Market Analysis by Segments, 2023 (%)

Interbody Devices Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the Interbody Devices pipeline market, download a free report sample

Interbody Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Interbody Devices market are the US, Europe, China, Australia, and the United Kingdom among others. As of July 2023, the US had the highest number of pipeline products.

Interbody Devices Pipeline Market Analysis by Territories, 2023 (%)

Interbody Devices Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the Interbody Devices pipeline market, download a free report sample

Interbody Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Interbody Devices pipeline market are 510(k), PMA, CE, NMPA, and TGA among others. As of July 2023, 510(k) was the most followed pathway for pipeline products.

Interbody Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Interbody Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Interbody Devices pipeline market, download a free report sample

Interbody Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Interbody Devices pipeline market are 3D Systems Inc, Acuitive Technologies Inc, Allegra Orthopaedics Ltd, ALM Ortho Inc, and Alphatec Holdings Inc among others.

Allegra Orthopaedics Ltd Company: Allegra Orthopaedics Ltd (Allegra), develops, manufactures, and sells prosthetic implants and related orthopedic medical devices. Its products include adult and adolescent clavicle fixation systems and pins, shoulder implants, proximal humeral plates, and splints among others. Allegra also provides integrated services to surgeons and hospitals. It offers manufacturing services such as instrument manufacturing and precision manufacturing to other companies. The company’s operations are predominantly in Australia. Allegra is headquartered in Lane Cove West, New South Wales, Australia.

Leading Interbody Devices Companies, 2023

Leading Interbody Devices Companies, 2023

For more company insights into the Interbody Devices pipeline market, download a free report sample

Segments Covered in the Report

Interbody Devices Pipeline Market Segments Outlook

  • PEEK Interbody Devices
  • Metal Interbody Devices
  • Other Interbody Devices (Ceramic, Carbon Fibre)
  • Machined Allograft Bone Interbody Devices

Interbody Devices Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • United Kingdom

Interbody Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • PMA
  • CE
  • NMPA
  • TGA

Scope

This report provides:

  • Extensive coverage of the Interbody Devices under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Interbody Devices and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Interbody Devices under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3D Systems Inc
Acuitive Technologies Inc
Allegra Orthopaedics Ltd
ALM Ortho Inc
Alphatec Holdings Inc
Biedermann Motech GmbH & Co KG
Bio2 Technologies Inc
Camber Spine Technologies LLC
Choice Spine LLC
Corelink LLC
CTL Amedica Corp
Cutting Edge Spine LLC
DePuy Synthes Inc
DSM Biomedical BV
Eminent Spine LLC
Evoke Medical LLC
Farmove Medical
Fuse Medical Inc
HAPPE Spine LLC
HD LifeSciences LLC
Innov'spine
Intelligent Implant Systems LLC
Jemo Spine, LLC.
LESspine LLC
Novum Medical Products, Inc.
Ozop Surgical Corp (Inactive)
Pharmaco-Kinesis Corp
SeaSpine, Inc.
SINTX Technologies Inc
Spinal Simplicity LLC
SpinalVu Inc (Inactive)
SpineSmith Holdings LLC
Stryker Corp
Taragenyx Ltd (Inactive)
Theradaptive Inc
TranS1 Inc
University of Pittsburgh
University of South Florida
VGI Medical LLC
Xtant Medical Holdings Inc
Xtremity & Spinal Solutions Ltd
Yunyi (Beijing) Medical Device Co Ltd
ZygoFix Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 10

2 Introduction 11

2.1 Interbody Devices Overview 11

3 Products under Development 12

3.1 Interbody Devices – Pipeline Products by Stage of Development 12

3.2 Interbody Devices – Pipeline Products by Segment 13

3.3 Interbody Devices – Pipeline Products by Territory 14

3.4 Interbody Devices – Pipeline Products by Regulatory Path 15

3.5 Interbody Devices – Pipeline Products by Estimated Approval Date 16

4 Interbody Devices – Pipeline Products under Development by Companies 17

4.1 Interbody Devices Companies – Pipeline Products by Stage of Development 17

4.2 Interbody Devices – Pipeline Products by Stage of Development 19

5 Interbody Devices Companies and Product Overview 21

5.1 3D Systems Inc Company Overview 21

5.1.1 3D Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Acuitive Technologies Inc Company Overview 22

5.2.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Allegra Orthopaedics Ltd Company Overview 23

5.3.1 Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 ALM Ortho Inc Company Overview 24

5.4.1 ALM Ortho Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Alphatec Holdings Inc Company Overview 25

5.5.1 Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Biedermann Motech GmbH & Co KG Company Overview 28

5.6.1 Biedermann Motech GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Bio2 Technologies Inc Company Overview 29

5.7.1 Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Camber Spine Technologies LLC Company Overview 31

5.8.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 Choice Spine LLC Company Overview 32

5.9.1 Choice Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 Corelink LLC Company Overview 33

5.10.1 Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 CTL Amedica Corp Company Overview 35

5.11.1 CTL Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Cutting Edge Spine LLC Company Overview 37

5.12.1 Cutting Edge Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.13 DePuy Synthes Inc Company Overview 38

5.13.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 DSM Biomedical BV Company Overview 39

5.14.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Eminent Spine LLC Company Overview 40

5.15.1 Eminent Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Evoke Medical LLC Company Overview 42

5.16.1 Evoke Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 Farmove Medical Company Overview 43

5.17.1 Farmove Medical Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 Fuse Medical Inc Company Overview 44

5.18.1 Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.19 HAPPE Spine LLC Company Overview 46

5.19.1 HAPPE Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 HD LifeSciences LLC Company Overview 49

5.20.1 HD LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.21 Innov’spine Company Overview 51

5.21.1 Innov’spine Pipeline Products & Ongoing Clinical Trials Overview 51

5.22 Intelligent Implant Systems LLC Company Overview 52

5.22.1 Intelligent Implant Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 52

5.23 Jemo Spine, LLC. Company Overview 53

5.23.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 53

5.24 LESspine LLC Company Overview 54

5.24.1 LESspine LLC Pipeline Products & Ongoing Clinical Trials Overview 54

5.25 Novum Medical Products, Inc. Company Overview 56

5.25.1 Novum Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

5.26 Ozop Surgical Corp (Inactive) Company Overview 58

5.26.1 Ozop Surgical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58

5.27 Pharmaco-Kinesis Corp Company Overview 59

5.27.1 Pharmaco-Kinesis Corp Pipeline Products & Ongoing Clinical Trials Overview 59

5.28 SeaSpine, Inc. Company Overview 60

5.28.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

5.29 SINTX Technologies Inc Company Overview 65

5.29.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.30 Spinal Simplicity LLC Company Overview 67

5.30.1 Spinal Simplicity LLC Pipeline Products & Ongoing Clinical Trials Overview 67

5.31 SpinalVu Inc (Inactive) Company Overview 68

5.31.1 SpinalVu Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 68

5.32 SpineSmith Holdings LLC Company Overview 70

5.32.1 SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 70

5.33 Stryker Corp Company Overview 72

5.33.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 72

5.34 Taragenyx Ltd (Inactive) Company Overview 74

5.34.1 Taragenyx Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74

5.35 Theradaptive Inc Company Overview 75

5.35.1 Theradaptive Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.36 TranS1 Inc Company Overview 76

5.36.1 TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.37 University of Pittsburgh Company Overview 77

5.37.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 77

5.38 University of South Florida Company Overview 78

5.38.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 78

5.39 VGI Medical LLC Company Overview 79

5.39.1 VGI Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 79

5.40 Xtant Medical Holdings Inc Company Overview 80

5.40.1 Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.41 Xtremity & Spinal Solutions Ltd Company Overview 81

5.41.1 Xtremity & Spinal Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

5.42 Yunyi (Beijing) Medical Device Co Ltd Company Overview 83

5.42.1 Yunyi (Beijing) Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

5.43 ZygoFix Ltd Company Overview 84

5.43.1 ZygoFix Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

6 Interbody Devices- Recent Developments 86

6.1 May 23, 2023: Aurora Spine schedules release of Q1 fiscal year 2023 financial results and conference call 86

6.2 May 18, 2023: Centinel Spine announces record worldwide motion preservation revenue in first quarter 2023 86

6.3 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 87

6.4 May 04, 2023: NuVasive announces conference call and webcast of Q1 2023 results 87

6.5 Apr 26, 2023: Aurora Spine schedules release of Q4 and fiscal year 2022 financial results and conference call 88

6.6 Apr 13, 2023: Safe group announces revenues of €1.5 million in Q1 2023 88

6.7 Apr 12, 2023: Medtronic has a layoff in California 89

6.8 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 89

6.9 Mar 16, 2023: Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023 89

6.10 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 89

6.11 Feb 14, 2023: Spineway Reports Full Year 2022 Earnings 90

6.12 Feb 09, 2023: Spinal Elements Appoints Ron Lloyd as President and Chief Executive Officer 90

6.13 Feb 09, 2023: Spineway announces 2022 annual results 90

6.14 Jan 09, 2023: ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility 91

6.15 Nov 23, 2022: Medtronic Reports Quarterly Earnings 93

6.16 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 93

6.17 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results 99

6.18 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 100

6.19 Nov 10, 2022: Surgalign aims to slash $30M from 2023 spending with planned layoffs 100

6.20 Nov 09, 2022: Safe announces the convocation of an extraordinary general meeting of the Company to be held on December 16, 2022 100

6.21 Nov 07, 2022: NuVasive launches tube system and excavation micro for posterior spine surgery 101

6.22 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting 101

6.23 Oct 10, 2022: ATEC Announces Select Preliminary Third Quarter 2022 Financial Results and Raises Guidance 102

6.24 Oct 06, 2022: Safe group announces its first semester financial results and Q3 sales 103

6.25 Oct 06, 2022: Integra LifeSciences appoints Harvinder Singh as Executive Vice President, President Of Co.”s International Business 105

6.26 Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment 105

6.27 Oct 04, 2022: Exactech Names New Chief Financial Officer 105

6.28 Sep 12, 2022: NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting 106

6.29 Sep 07, 2022: Medtronic to appear at September investor conferences 106

6.30 Aug 30, 2022: ATEC to Participate in Upcoming Investor Conferences 106

6.31 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 106

6.32 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 109

6.33 Aug 12, 2022: Sintx Technologies Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 112

6.34 Aug 04, 2022: ATEC Reports Second Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance 113

6.35 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results 113

6.36 Jul 26, 2022: ATEC to Participate in Upcoming Investor Conferences 115

6.37 Jul 21, 2022: ATEC to Report Second Quarter 2022 Financial Results on August 4 2022 115

7 Appendix 116

7.1 Methodology 116

7.2 About GlobalData 119

7.3 Contact Us 119

7.4 Disclaimer 119

Table

Interbody Devices – Pipeline Products by Stage of Development 12

Interbody Devices – Pipeline Products by Segment 13

Interbody Devices – Pipeline Products by Territory 14

Interbody Devices – Pipeline Products by Regulatory Path 15

Interbody Devices – Pipeline Products by Estimated Approval Date 16

Interbody Devices Companies – Pipeline Products by Stage of Development 17

Interbody Devices – Pipeline Products by Stage of Development 19

3D Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Spinal Cage – Product Status 21

Spinal Cage – Product Description 21

Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Citrefuse – Product Status 22

Citrefuse – Product Description 22

Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Sr-HT-Gahnite Spinal Cage Device – Product Status 23

Sr-HT-Gahnite Spinal Cage Device – Product Description 23

ALM Ortho Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Lateral Intervertebral Fusion Cage – Product Status 24

Lateral Intervertebral Fusion Cage – Product Description 24

Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Lateral Interbody with Expandable Cage – Product Status 25

Lateral Interbody with Expandable Cage – Product Description 25

PCB – Product Status 26

PCB – Product Description 26

Samarys RF – Product Status 26

Samarys RF – Product Description 27

Biedermann Motech GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview 28

Mesh – Product Status 28

Mesh – Product Description 28

Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Vitrium – Cervical Interbody Fusion Device – Product Status 29

Vitrium – Cervical Interbody Fusion Device – Product Description 29

Vitrium – Lumbar Interbody Fusion Device – Product Status 30

Vitrium – Lumbar Interbody Fusion Device – Product Description 30

Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 31

SPIRA – Expandable Transforaminal Lumbar Interbody – Product Status 31

SPIRA – Expandable Transforaminal Lumbar Interbody – Product Description 31

Choice Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 32

Expandable PEEK Interbody Cage – Product Status 32

Expandable PEEK Interbody Cage – Product Description 32

Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview 33

3D Printed Cervical Titanium Interbody System – Product Status 33

3D Printed Cervical Titanium Interbody System – Product Description 33

3D Printed Lumbar Titanium Interbody System – Product Status 34

3D Printed Lumbar Titanium Interbody System – Product Description 34

CTL Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 35

MONDRIAN PLIF Cage – Product Status 35

MONDRIAN PLIF Cage – Product Description 35

MONDRIAN TLIF Cage – Product Status 36

MONDRIAN TLIF Cage – Product Description 36

Cutting Edge Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 37

EVOL HA-ALIF – Product Status 37

EVOL HA-ALIF – Product Description 37

DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 38

TLIF Cage – Product Status 38

TLIF Cage – Product Description 38

DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 39

Spine Inter-Body Fusion Cage – Product Status 39

Spine Inter-Body Fusion Cage – Product Description 39

Eminent Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 40

King Snake – Product Status 40

King Snake – Product Description 40

Queen Snake – Product Status 41

Queen Snake – Product Description 41

Evoke Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 42

eHeal – Product Status 42

eHeal – Product Description 42

Farmove Medical Pipeline Products & Ongoing Clinical Trials Overview 43

Interbody Fusion Device – Product Status 43

Interbody Fusion Device – Product Description 43

Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Cervical Spinal Interbody Device – Product Status 44

Cervical Spinal Interbody Device – Product Description 44

Lumbar Spinal Interbody Device – Product Status 45

Lumbar Spinal Interbody Device – Product Description 45

HAPPE Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 46

Cervical Peek Interbody Device – Product Status 46

Cervical Peek Interbody Device – Product Description 46

Lumbar PEEK Interbody Device – ALIF – Product Status 47

Lumbar PEEK Interbody Device – ALIF – Product Description 47

Lumbar PEEK Interbody Device – TLIF – Product Status 47

Lumbar PEEK Interbody Device – TLIF – Product Description 48

HD LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Hive Cervical – Product Status 49

Hive Cervical – Product Description 49

Hive Cervical S – Product Status 50

Hive Cervical S – Product Description 50

Innov’spine Pipeline Products & Ongoing Clinical Trials Overview 51

Intersomatic Cervical Implant – Product Status 51

Intersomatic Cervical Implant – Product Description 51

Intelligent Implant Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 52

LSIF – Product Status 52

LSIF – Product Description 52

Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 53

Moab Interbody Spacer – Product Status 53

Moab Interbody Spacer – Product Description 53

LESspine LLC Pipeline Products & Ongoing Clinical Trials Overview 54

Expanding P-Lift – Product Status 54

Expanding P-Lift – Product Description 54

X-Visibl – Product Status 55

X-Visibl – Product Description 55

Novum Medical Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

Anterior Lumbar Interbody Fusion Device – Product Status 56

Anterior Lumbar Interbody Fusion Device – Product Description 56

Lateral Lumbar Interbody Fusion Device – Product Status 57

Lateral Lumbar Interbody Fusion Device – Product Description 57

Ozop Surgical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 58

Adjustable ALIF Interbody Spinal Implant – Product Status 58

Adjustable ALIF Interbody Spinal Implant – Product Description 58

Pharmaco-Kinesis Corp Pipeline Products & Ongoing Clinical Trials Overview 59

Intelligent Interbody Fusion Device – Product Status 59

Intelligent Interbody Fusion Device – Product Description 59

SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

3D-Printed Lateral Lumbar Interbody Device – Product Status 60

3D-Printed Lateral Lumbar Interbody Device – Product Description 60

3D-Printed Lumbar Interbody Device – Anterior Approach – Product Status 61

3D-Printed Lumbar Interbody Device – Anterior Approach – Product Description 61

ALIF With Locking Plate – Product Status 61

ALIF With Locking Plate – Product Description 61

Lateral Intervertebral Body Fusion Device – Product Status 62

Lateral Intervertebral Body Fusion Device – Product Description 62

Lordotic And Parallel Expandable PLIF Interbody Device – Product Status 62

Lordotic And Parallel Expandable PLIF Interbody Device – Product Description 62

Next Gen PLIF/TLIF Oblique Interbody Device – Product Status 63

Next Gen PLIF/TLIF Oblique Interbody Device – Product Description 63

Next Gen TLIF Articulating Anterior Interbody Device – Product Status 63

Next Gen TLIF Articulating Anterior Interbody Device – Product Description 64

SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Biologically Enhanced Spinal Fusion Device – Product Status 65

Biologically Enhanced Spinal Fusion Device – Product Description 65

Composite Silicon Nitride Interbody Device – Product Status 66

Composite Silicon Nitride Interbody Device – Product Description 66

Spinal Simplicity LLC Pipeline Products & Ongoing Clinical Trials Overview 67

Scarab – Product Status 67

Scarab – Product Description 67

SpinalVu Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 68

X – Wave Cervical Interbody Spacer – Product Status 68

X – Wave Cervical Interbody Spacer – Product Description 68

X – Wave Lumbar Interbody Spacer – Product Status 69

X – Wave Lumbar Interbody Spacer – Product Description 69

SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 70

Closed VisuALIF – Product Status 70

Closed VisuALIF – Product Description 70

Posterior Lumbar Interbody Fusion Device – Product Status 71

Posterior Lumbar Interbody Fusion Device – Product Description 71

Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 72

AlloCraft C-Ring – Product Status 72

AlloCraft C-Ring – Product Description 72

Bioactive Inter-body Device – Product Status 73

Bioactive Inter-body Device – Product Description 73

Taragenyx Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74

TRGYX-001 – Product Status 74

TRGYX-001 – Product Description 74

Theradaptive Inc Pipeline Products & Ongoing Clinical Trials Overview 75

OsteoAdapt SP Spinal Fusion Implant – Product Status 75

OsteoAdapt SP Spinal Fusion Implant – Product Description 75

TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 76

KeyLIF – Product Status 76

KeyLIF – Product Description 76

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 77

Self-Powered Smart Implant – Product Status 77

Self-Powered Smart Implant – Product Description 77

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 78

Asymmetric Disc Distracting Cage – Product Status 78

Asymmetric Disc Distracting Cage – Product Description 78

VGI Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 79

VerteLX – Product Status 79

VerteLX – Product Description 79

Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Interbody Fusion Device – Product Status 80

Interbody Fusion Device – Product Description 80

Xtremity & Spinal Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

FILL AND FIX PEEK OPTIMA ANATOMIC Cervical Cage – Product Status 81

FILL AND FIX PEEK OPTIMA ANATOMIC Cervical Cage – Product Description 81

FILL AND FIX PEEK OPTIMA ANATOMIC Lumbar Cage – Product Status 82

FILL AND FIX PEEK OPTIMA ANATOMIC Lumbar Cage – Product Description 82

Yunyi (Beijing) Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

3D Printed PEEK Artificial Vertebral Body – Product Status 83

3D Printed PEEK Artificial Vertebral Body – Product Description 83

ZygoFix Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

ZLock Cervical Implant – Product Status 84

ZLock Cervical Implant – Product Description 84

ZLock SI Implant – Product Status 85

ZLock SI Implant – Product Description 85

Glossary 118

Figures

Interbody Devices – Pipeline Products by Stage of Development 12

Interbody Devices – Pipeline Products by Segment 13

Interbody Devices – Pipeline Products by Territory 14

Interbody Devices – Pipeline Products by Regulatory Path 15

Interbody Devices – Pipeline Products by Estimated Approval Date 16

Frequently asked questions

Interbody Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Interbody Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Interbody Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Interbody Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.